This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

[video] Auto Stocks Won't Stall in Coming Year

NEW YORK (TheStreet) -- Keep the pedal to the metal on automaker stocks in 2014.

"I think we are going to have another good year in 2014," says Efraim Levy, equity analyst for S&P Capital IQ. "Even if interest rates increase, I don't think it will have a large impact on demand because the economy is improving and a slight increase in car payments won't stop you from buying a car, especially if you have a new job and you need to get to work."

Levy sees 16.1 million new light vehicles hitting the road in the coming year, a 3.3% rise from last year's estimate of 15.6 million. He expects GM (GM - Get Report) to lead the way in the next 12 months. GM made huge strides in 2013 with the appointment of Mary Barra as its new CEO, as well as Uncle Sam finally selling its stake in the company. Shares of GM finished up 41% in 2013, a full 12 percentage points better than the benchmark S&P.

"We are talking about a company that's solidly in recovery mode," says Levy. "There will be a lot of continuity, but there will also be her imprint going forward, so we expect good things."

Levy is also bullish on GM rival Ford (F - Get Report) which saw its shares rise around 19% in 2013. And he believes Ford CEO Alan Mulally will finish the year at the company, despite rampant rumors that he is a candidate to replace Steve Ballmer at Microsoft (MSFT).

"I'm making the bet that he will be there through the end of year," says Levy. "But even if he leaves, Ford has the bench strength in my opinion to continue their progress and growth."

And while Tesla (TSLA - Get Report) had the best year of any auto manufacturer with its shares rising over 340%, Levy is cautioning investors to hold off on buying the heavily shorted stock due to its nosebleed multiple.

"We like the fundamentals, the story is there and the growth will be there, but right now the valuation is also very much there at over 100 times their 2014 earnings estimate it's kind of pricey."

-- Written by Gregg Greenberg

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
F $15.78 -0.19%
GM $35.40 -0.06%
TSLA $230.51 1.98%
AAPL $128.70 -0.19%
FB $78.81 -0.23%

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs